ArticleThe oncologist2020

Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD-L1 Expression.

Xiaobo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.